BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27216827)

  • 21. Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases.
    van Assen S; Elkayam O; Agmon-Levin N; Cervera R; Doran MF; Dougados M; Emery P; Geborek P; Ioannidis JP; Jayne DR; Kallenberg CG; Müller-Ladner U; Shoenfeld Y; Stojanovich L; Valesini G; Wulffraat NM; Bijl M
    Autoimmun Rev; 2011 Apr; 10(6):341-52. PubMed ID: 21182987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rituximab Therapy and Infection Risk in Pediatric Renal Transplant Patients.
    Gulleroglu K; Baskin E; Moray G; Ozdemir H; Arslan H; Haberal M
    Exp Clin Transplant; 2016 Apr; 14(2):172-5. PubMed ID: 26742572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preventing infectious complications when treating non-malignant immune-mediated hematologic disorders.
    Malpica L; van Duin D; Moll S
    Am J Hematol; 2019 Dec; 94(12):1396-1412. PubMed ID: 31571266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccination in patients under monoclonal antibody treatment: an updated comprehensive review.
    Rivera-Izquierdo M; Valero-Ubierna MDC; Nieto-Gómez P; Martínez-Bellón MD; Fernández-Martínez NF; Barranco-Quintana JL
    Expert Rev Vaccines; 2020 Aug; 19(8):727-744. PubMed ID: 32702246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Literature-based immunization recommendations for patients requiring immunosuppressive medications for autoimmune bullous dermatoses.
    Laniosz V; Lehman JS; Poland GA; Wetter DA
    Int J Dermatol; 2016 Jun; 55(6):599-607. PubMed ID: 26711431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Vaccination].
    Graubner UB; Liese J; Belohradsky BH
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A77-83. PubMed ID: 11577366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunization recommendations for adults with cancer.
    Arrowood JR; Hayney MS
    Ann Pharmacother; 2002; 36(7-8):1219-29. PubMed ID: 12086557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dentists' awareness toward vaccine preventable diseases.
    Petti S; Messano GA; Polimeni A
    Vaccine; 2011 Oct; 29(45):8108-12. PubMed ID: 21856363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization and vaccine-preventable illness, United States, 1992 to 1997.
    Teitelbaum MA; Edmunds M
    Stat Bull Metrop Insur Co; 1999; 80(2):13-20. PubMed ID: 10327522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biodegradable polymeric microsphere-based vaccines and their applications in infectious diseases.
    Lin CY; Lin SJ; Yang YC; Wang DY; Cheng HF; Yeh MK
    Hum Vaccin Immunother; 2015; 11(3):650-6. PubMed ID: 25839217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adolescents and vaccines in the western world.
    Principi N; Esposito S
    Vaccine; 2013 Nov; 31(46):5366-74. PubMed ID: 24029116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination of children and adolescents with rheumatic diseases.
    Dell' Era L; Esposito S; Corona F; Principi N
    Rheumatology (Oxford); 2011 Aug; 50(8):1358-65. PubMed ID: 21482543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are cirrhotic patients awaiting liver transplantation protected against vaccine-preventable diseases?
    Mazzola A; Minh MT; Jauréguiberry S; Bernard D; Lebray P; Chrétien Y; Goumard C; Calmus Y; Conti F
    Clin Microbiol Infect; 2018 Jul; 24(7):787-788. PubMed ID: 29496596
    [No Abstract]   [Full Text] [Related]  

  • 34. Vaccination recommendations for adult patients with autoimmune inflammatory rheumatic diseases.
    Bühler S; Eperon G; Ribi C; Kyburz D; van Gompel F; Visser LG; Siegrist CA; Hatz C
    Swiss Med Wkly; 2015; 145():w14159. PubMed ID: 26218860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune surveillance for vaccine-preventable diseases.
    den Hartog G; van Binnendijk R; Buisman AM; Berbers GAM; van der Klis FRM
    Expert Rev Vaccines; 2020 Apr; 19(4):327-339. PubMed ID: 32223469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The promise and challenge of epitope-focused vaccines.
    Oscherwitz J
    Hum Vaccin Immunother; 2016 Aug; 12(8):2113-2116. PubMed ID: 27058686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination issues in patients with chronic kidney disease.
    Mathew R; Mason D; Kennedy JS
    Expert Rev Vaccines; 2014 Feb; 13(2):285-98. PubMed ID: 24405403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response of transplant recipients to influenza vaccination based on type of immunosuppression: A meta-analysis.
    Karbasi-Afshar R; Izadi M; Fazel M; Khedmat H
    Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):877-83. PubMed ID: 26354557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Rheumatic patients with immunosuppressive therapy: which vaccinations are safe, which ones taboo].
    Arnheim K
    MMW Fortschr Med; 2008 May; 150(22):18. PubMed ID: 18697412
    [No Abstract]   [Full Text] [Related]  

  • 40. Vaccines: Considerations for pediatric dermatology patients on immunosuppressive agents.
    Munshi MA; Noe MH; Chiu YE; Streicher JL
    Pediatr Dermatol; 2021 Sep; 38(5):1040-1046. PubMed ID: 34060143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.